NMS · Medical - Devices
Orthofix Medical Inc. (OFIX) Stock
$9.09
+1.00%
NMS: OFIX
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Orthofix to Report Second Quarter 2026 Financial Results
Business Wire · Jul 15, 2026
Sector Update: Healthcare Stocks Fall Late Afternoon
MT Newswires · Jul 6, 2026
Sector Update: Healthcare
MT Newswires · Jul 6, 2026
Orthofix Medical Shares Rise After Medicare Billing for Bone Growth Stimulators Expected to Return to Prior Rates
MT Newswires · Jul 6, 2026
Barrington Raises Price Target on Orthofix Medical to $17 From $15, Keeps Outperform Rating
MT Newswires · Jul 6, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Orthofix Medical Inc.
Orthofix Medical Inc. is led by CEO Massimo Calafiore, employs 1,616 people, headquartered in US, publicly traded since 1992.
Orthofix Medical Inc. (OFIX) stock trades at $9.09 with a market capitalization of $367.43M. The stock is valued at a price-to-earnings (P/E) ratio of -5.92, price-to-book of 0.87, price-to-sales of 0.44. Over the past 52 weeks the stock has ranged between $8.50 and $16.99, and currently trades 46.5% below its 52-week high.
On profitability, Orthofix Medical Inc. generates a return on equity (ROE) of -14.05%, return on capital employed of -3.55%, an operating margin of -8.27%, a net profit margin of -7.41%.